Changes in hemodynamics due to the contrast medium during left ventriculography

Angiology. 1987 Nov;38(11):825-32. doi: 10.1177/000331978703801104.

Abstract

Seventeen patients with heart diseases examined by left ventricular angiography were divided into two groups consisting of those with a clinical history of heart failure (CHF+) and those without (CHF-). Changes in hemodynamics, circulating blood volume, and plasma volume due to injection of the contrast medium were studied, and the following results were obtained. Both the CHF- and CHF+ groups showed an increase in heart rate after injection of the contrast medium, but a statistically significant difference (p less than 0.05) was noted only at one and two minutes after angiography in both groups. Left ventricular systolic pressure decreased after injection of the contrast medium in both groups, but the CHF+ group required a longer time for recovery. In the CHF- group, the left ventricular end-diastolic pressure increased slightly after injection of the contrast medium, but in the CHF+ group it increased markedly with a statistically significant difference (p less than 0.01). Stroke volume, measured by a noninvasive, continuous cardiac output monitor according to the impedance method, increased upon injection of the contrast medium in the CHF- group. However, in the CHF+ group it decreased, although no statistically significant difference was noted in either group. Cardiac index increased markedly upon injection of the contrast medium in the CHF- group with a statistically significant difference (p less than 0.01), but hardly any change was observed in the CHF+ group.(ABSTRACT TRUNCATED AT 250 WORDS)

MeSH terms

  • Angiocardiography / adverse effects*
  • Blood Pressure / drug effects
  • Blood Volume / drug effects
  • Cardiac Output / drug effects
  • Diatrizoate Meglumine / adverse effects*
  • Female
  • Heart Diseases / diagnostic imaging
  • Heart Diseases / physiopathology*
  • Heart Rate / drug effects
  • Hemodynamics / drug effects*
  • Humans
  • Male
  • Middle Aged
  • Stroke Volume / drug effects

Substances

  • Diatrizoate Meglumine